Resveratrol: Biological and Pharmaceutical Properties As Anticancer Molecule

Overview

Journal Biofactors

Publisher IOS Press

Specialty Biochemistry

Date 2010 Jul 13

PMID 20623546

Citations 37

Authors

Tze-Chen Hsieh

Joseph M Wu

Affiliations

Soon will be listed here.

Abstract

There is ample evidence that shows an inverse relationship between consumption of fruit/vegetable-rich diets and the risk of cancer at various anatomical sites. In this review, we will assess and summarize recent advances on cancer prevention by resveratrol, a natural stilbenoid present in red grapes, peanuts, some common drinks, and dietary supplements. We will focus on data published within the past few years on in vivo model tumor animal studies that reinforce the chemopreventive efficacy of resveratrol against a multitude of cancers, as well as on its sensitization/enhancing activities against tumor cells when used in combination with established chemotherapeutic and pharmaceutical agents. In addition, we will review examples resveratrol-target proteins, denoted RTPs, including the 24-kDa cytosolic protein quinone reductase 2 (NQO2) discovered in our laboratory that may confer resveratrol responsiveness to cancer cells. We will discuss the possible role of NQO2 in mediating cancer prevention by resveratrol. Our analysis of published data strengthen support that resveratrol displays novel roles in various cellular processes, and help to establish an expanded molecular framework for cancer prevention by resveratrol in vivo.

Citing Articles

Back to the Basics of SARS-CoV-2 Biochemistry: Microvascular Occlusive Glycan Bindings Govern Its Morbidities and Inform Therapeutic Responses.

Scheim D, Parry P, Rabbolini D, Aldous C, Yagisawa M, Clancy R Viruses. 2024; 16(4).

PMID: 38675987 PMC: 11054389. DOI: 10.3390/v16040647.

Review on Natural Agents as Aromatase Inhibitors: Management of Breast Cancer.

Singh S Comb Chem High Throughput Screen. 2023; 27(18):2623-2638.

PMID: 37861041 DOI: 10.2174/0113862073269599231009115338.

Bioactive Phytoconstituents and Their Therapeutic Potentials in the Treatment of Haematological Cancers: A Review.

Iweala E, Oluwapelumi A, Dania O, Ugbogu E Life (Basel). 2023; 13(7).

PMID: 37511797 PMC: 10381774. DOI: 10.3390/life13071422.

Brain targeting based nanocarriers loaded with resveratrol in Alzheimer's disease: A review.

Jalili C, Kiani A, Gholami M, Bahrehmand F, Fakhri S, Kakehbaraei S IET Nanobiotechnol. 2023; 17(3):154-170.

PMID: 36949020 PMC: 10190566. DOI: 10.1049/nbt2.12127.

T lymphocyte cell: A pivotal player in lung cancer.

Wu Y, Yuan M, Wang C, Chen Y, Zhang Y, Zhang J Front Immunol. 2023; 14:1102778.

PMID: 36776832 PMC: 9911803. DOI: 10.3389/fimmu.2023.1102778.

References

Wang T, Schoene N, Kim Y, Mizuno C, Rimando A . Differential effects of resveratrol and its naturally occurring methylether analogs on cell cycle and apoptosis in human androgen-responsive LNCaP cancer cells. Mol Nutr Food Res. 2010; 54(3):335-44. DOI: 10.1002/mnfr.200900143. View

Yusuf N, Nasti T, Meleth S, Elmets C . Resveratrol enhances cell-mediated immune response to DMBA through TLR4 and prevents DMBA induced cutaneous carcinogenesis. Mol Carcinog. 2009; 48(8):713-23. PMC: 2760377. DOI: 10.1002/mc.20517. View

Kuo P, Chiang L, Lin C . Resveratrol- induced apoptosis is mediated by p53-dependent pathway in Hep G2 cells. Life Sci. 2002; 72(1):23-34. DOI: 10.1016/s0024-3205(02)02177-x. View

Athar M, Back J, Kopelovich L, Bickers D, Kim A . Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms. Arch Biochem Biophys. 2009; 486(2):95-102. PMC: 2749321. DOI: 10.1016/j.abb.2009.01.018. View

Wang T, Hudson T, Wang T, Remsberg C, Davies N, Takahashi Y . Differential effects of resveratrol on androgen-responsive LNCaP human prostate cancer cells in vitro and in vivo. Carcinogenesis. 2008; 29(10):2001-10. PMC: 2722852. DOI: 10.1093/carcin/bgn131. View

Shankar S, Siddiqui I, Srivastava R . Molecular mechanisms of resveratrol (3,4,5-trihydroxy-trans-stilbene) and its interaction with TNF-related apoptosis inducing ligand (TRAIL) in androgen-insensitive prostate cancer cells. Mol Cell Biochem. 2007; 304(1-2):273-85. DOI: 10.1007/s11010-007-9510-x. View

Hsieh T, Wu J . Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines. Exp Cell Res. 1999; 249(1):109-15. DOI: 10.1006/excr.1999.4471. View

Roman V, Billard C, Kern C, Ferry-Dumazet H, Izard J, Mohammad R . Analysis of resveratrol-induced apoptosis in human B-cell chronic leukaemia. Br J Haematol. 2002; 117(4):842-51. DOI: 10.1046/j.1365-2141.2002.03520.x. View

Ferry-Dumazet H, Garnier O, Mamani-Matsuda M, Vercauteren J, Belloc F, Billiard C . Resveratrol inhibits the growth and induces the apoptosis of both normal and leukemic hematopoietic cells. Carcinogenesis. 2002; 23(8):1327-33. DOI: 10.1093/carcin/23.8.1327. View

10.

Johnson G, Ivanov V, Hei T . Radiosensitization of melanoma cells through combined inhibition of protein regulators of cell survival. Apoptosis. 2008; 13(6):790-802. PMC: 4374428. DOI: 10.1007/s10495-008-0212-y. View

11.

Waters M . Aromatic interactions in model systems. Curr Opin Chem Biol. 2002; 6(6):736-41. DOI: 10.1016/s1367-5931(02)00359-9. View

12.

Kundu J, Surh Y . Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives. Cancer Lett. 2008; 269(2):243-61. DOI: 10.1016/j.canlet.2008.03.057. View

13.

Bishayee A . Cancer prevention and treatment with resveratrol: from rodent studies to clinical trials. Cancer Prev Res (Phila). 2009; 2(5):409-18. DOI: 10.1158/1940-6207.CAPR-08-0160. View

14.

Hsieh T, Wang Z, Deng H, Wu J . Identification of glutathione sulfotransferase-pi (GSTP1) as a new resveratrol targeting protein (RTP) and studies of resveratrol-responsive protein changes by resveratrol affinity chromatography. Anticancer Res. 2008; 28(1A):29-36. PMC: 2405911. View

15.

Harper C, Cook L, Patel B, Wang J, Eltoum I, Arabshahi A . Genistein and resveratrol, alone and in combination, suppress prostate cancer in SV-40 tag rats. Prostate. 2009; 69(15):1668-82. PMC: 2758814. DOI: 10.1002/pros.21017. View

16.

Kweon S, Song J, Kim T . Resveratrol-mediated reversal of doxorubicin resistance in acute myeloid leukemia cells via downregulation of MRP1 expression. Biochem Biophys Res Commun. 2010; 395(1):104-10. DOI: 10.1016/j.bbrc.2010.03.147. View

17.

Ivanov V, Partridge M, Johnson G, Huang S, Zhou H, Hei T . Resveratrol sensitizes melanomas to TRAIL through modulation of antiapoptotic gene expression. Exp Cell Res. 2008; 314(5):1163-76. PMC: 3738302. DOI: 10.1016/j.yexcr.2007.12.012. View

18.

Scarlatti F, Sala G, Ricci C, Maioli C, Milani F, Minella M . Resveratrol sensitization of DU145 prostate cancer cells to ionizing radiation is associated to ceramide increase. Cancer Lett. 2007; 253(1):124-30. DOI: 10.1016/j.canlet.2007.01.014. View

19.

Towler M, Grahame Hardie D . AMP-activated protein kinase in metabolic control and insulin signaling. Circ Res. 2007; 100(3):328-41. DOI: 10.1161/01.RES.0000256090.42690.05. View

20.

Zykova T, Zhu F, Zhai X, Ma W, Ermakova S, Lee K . Resveratrol directly targets COX-2 to inhibit carcinogenesis. Mol Carcinog. 2008; 47(10):797-805. PMC: 2562941. DOI: 10.1002/mc.20437. View